Dr. Martens (DOCS)

Sector:

Personal Goods

Index:

FTSE 250

80.50p
   
  • Change Today:
      3.05p
  • 52 Week High: 85.55
  • 52 Week Low: 47.52
  • Currency: UK Pounds
  • Shares Issued: 965.23m
  • Volume: 300,963
  • Market Cap: £777.01m

Latest Deals

Traded Action Notifier PriceAmountValue
12-May-25 Transfer From Giles Wilson 0.000p 261 £0.00
12-May-25 Buy Giles Wilson 57.45p 261 £149.94
11-Apr-25 Transfer From Giles Wilson 0.000p 297 £0.00
11-Apr-25 Buy Giles Wilson 50.55p 297 £150.13
08-Apr-25 Buy Giles Wilson 46.92p 58 £27.21

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
24-Sep-24 Buy Robyn Perriss 51.55p 89,054 £45,907.34
24-Sep-24 Sell Robyn Perriss 51.50p 89,054 £45,862.81
24-Sep-24 Buy Andrew Harrison 51.53p 58,220 £29,999.54
27-Aug-24 Buy Lynne Weedall 74.41p 25,000 £18,603.62
25-Mar-25 Buy Giles Wilson 54.01p 32,640 £17,628.31

Director Shareholdings

Notifier Holding Value*
Paul Mason 7,875,000 £6,339,375
Giles Wilson 110,713 £89,124
Robyn Perriss 94,328 £75,934
Andrew Harrison 76,594 £61,658
Lynne Weedall 40,054 £32,244
Ian Rogers 20,270 £16,317
Ije Nwokori 5,405 £4,351

Major Shareholders

Notifier** Holding Value*
IngreLux S.àr.l 369,942,440 £297,803,664
IngreGrsy Limited 369,942,440 £297,803,664
Permira Holdings Limited 364,142,440 £293,134,664
Artemis Investment Management LLP 86,997,521 £70,033,004
Fidelity Management & Research 32,500,000 £26,162,500
Intertrust Employee Benefit Trustee Limited 135,000 £108,675

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Dr. Martens Market Data

Currency UK Pounds
Share Price 80.50p
Change Today 3.05p
% Change 3.94 %
52 Week High 85.55
52 Week Low 47.52
Volume 300,963
Shares Issued 965.23m
Market Cap £777.01m

Dr. Martens Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
25.73% below the market average25.73% below the market average25.73% below the market average25.73% below the market average25.73% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Price Trend
24.06% below the market average24.06% below the market average24.06% below the market average24.06% below the market average24.06% below the market average
Sector averageSector averageSector averageSector averageSector average
Income
38.08% below the market average38.08% below the market average38.08% below the market average38.08% below the market average38.08% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
99.53% below the market average99.53% below the market average99.53% below the market average99.53% below the market average99.53% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Dr. Martens Dividends

  Latest Previous
  Final Interim
Ex-Div 28-Aug-25 06-Mar-25
Paid 08-Oct-25 08-Apr-25
Amount 1.70p 0.85p

Trades for 10-Jun-2025

Time Volume / Share Price
11:23 210 @ 80.63p
11:23 210 @ 80.63p
11:23 326 @ 80.50p
11:23 171 @ 80.55p
11:23 621 @ 80.60p

Dr. Martens Key Personnel

Chair Paul Mason
CEO Ije Nwokori
CFO Giles Wilson

Top of Page